Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

An extended phase II trial of iodine-125 methylene blue for sentinel lymph node identification in women with breast cancer.

Harkrider WW, Diebold AE, Maloney T, Espenan G, Wang YZ, Stafford SJ, Camp A, Frey D, Chappuis C, Woltering EA.

J Am Coll Surg. 2013 Apr;216(4):599-605; discussion 605-6. doi: 10.1016/j.jamcollsurg.2012.12.044.

PMID:
23521938
2.

A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy.

Cundiff JD, Wang YZ, Espenan G, Maloney T, Camp A, Lazarus L, Stolier A, Brooks R, Torrance B, Stafford S, O'Leary JP, Woltering EA.

Ann Surg. 2007 Feb;245(2):290-6.

4.

Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid.

Solorzano CC, Ross MI, Delpassand E, Mirza N, Akins JS, Kuerer HM, Meric F, Ames FC, Newman L, Feig B, Singletary SE, Hunt KK.

Ann Surg Oncol. 2001 Dec;8(10):821-7.

PMID:
11776497
5.

Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer.

Johnson CB, Boneti C, Korourian S, Adkins L, Klimberg VS.

Ann Surg. 2011 Oct;254(4):612-8. doi: 10.1097/SLA.0b013e31823005bf.

PMID:
21918427
6.

Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.

Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, Gibson R, Mancino A, Korourian S, Klimberg VS.

Ann Surg. 2004 Jun;239(6):841-5; discussion 845-8.

7.

Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma.

Huang O, Wu W, Wang O, You J, Li Q, Huang D, Hu X, Qu J, Jin C, Xiang Y, Yang K, Zhou S, Chen X, Pan Y, Guo G, Zhang X.

BMC Cancer. 2011 Sep 2;11:386. doi: 10.1186/1471-2407-11-386.

8.

Development of 125I-methylene blue for sentinel lymph node biopsy.

Stafford SJ, Wright JL, Schwimer J, Anthony CT, Cundiff JD, Thomson JL, Wang YZ, Espenan G, Maloney T, Camp A, Woltering EA.

J Surg Oncol. 2006 Sep 15;94(4):293-7.

PMID:
16917874
9.

Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.

Kargozaran H, Shah M, Li Y, Beckett L, Gandour-Edwards R, Schneider PD, Khatri VP.

J Surg Res. 2007 Nov;143(1):126-9.

PMID:
17950081
10.

Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.

Goyal A, Newcombe RG, Chhabra A, Mansel RE; ALMANAC Trialists Group.

Breast Cancer Res Treat. 2006 Sep;99(2):203-8. Epub 2006 Mar 16.

PMID:
16541308
11.

Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.

Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michigishi T, Tonami N, Minato H, Nonomura A.

Breast Cancer. 2000 Jan;7(1):87-94.

PMID:
11029778
12.

Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification.

Zogakis TG, Wetherille RE, Christensen RD, Ose KJ, Friedman JD, Colbert M, Svendsen CA, Sanan OK, Tuttle TM.

Ann Surg Oncol. 2005 Feb;12(2):167-72. Epub 2005 Jan 25.

PMID:
15827798
13.

Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.

Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK.

Clin Nucl Med. 2005 Jan;30(1):11-5.

PMID:
15604959
14.

A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma.

Liu Y, Truini C, Ariyan S.

Ann Surg Oncol. 2008 Sep;15(9):2412-7. doi: 10.1245/s10434-008-9953-7. Epub 2008 Jun 25.

PMID:
18581184
15.

[Intraoperative injection of technetium-99m-dextran 500 for the identification of sentinel lymph node in breast cancer].

Delazeri GJ, Xavier NL, Menke CH, Bittelbrunn AC, Spiro BL, Mosmann MP, Graudenz MS.

Rev Bras Ginecol Obstet. 2010 Oct;32(10):486-90. Portuguese.

16.

Intraoperative injection of technetium-99m sulfur colloid is effective in the detection of sentinel lymph nodes in breast cancer.

Dauphine CE, Khalkhali I, Vargas MP, Isaac NM, Haukoos J, Vargas HI.

Am J Surg. 2006 Oct;192(4):423-6.

PMID:
16978942
17.

Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.

Olson JA Jr, Fey J, Winawer J, Borgen PI, Cody HS 3rd, Van Zee KJ, Petrek J, Heerdt AS.

J Am Coll Surg. 2000 Dec;191(6):593-9.

PMID:
11129806
18.

Methylene blue dye, an accurate dye for sentinel lymph node identification in early breast cancer.

Mathelin C, Croce S, Brasse D, Gairard B, Gharbi M, Andriamisandratsoa N, Bekaert V, Francis Z, Guyonnet JL, Huss D, Salvador S, Schaeffer R, Grucker D, Marin C, Bellocq JP.

Anticancer Res. 2009 Oct;29(10):4119-25.

19.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
20.

Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.

Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS.

Ann Surg. 1998 May;227(5):645-51; discussion 651-3.

Supplemental Content

Support Center